{
    "nctId": "NCT04250818",
    "briefTitle": "Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile",
    "officialTitle": "Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile",
    "overallStatus": "SUSPENDED",
    "conditions": "Metastatic Triple-Negative Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Progression free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of metastatic triple negative breast cancer\n* 18 years of age or older\n\nExclusion Criteria:\n\n* Younger than 18\n* Unwilling to participate or unable to give informed consent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}